(Q36030759)

English

Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases (English)

1 reference

Europe PubMed Central

11 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

object named as

Shang-Fu Chen

7

0 references

object named as

Shuang Hou

11

0 references

14

object named as

Jiaoti Huang

1 reference

Europe PubMed Central

11 August 2017

author name string

Jie-Fu Chen

1

1 reference

Europe PubMed Central

11 August 2017

Hao Ho

2

1 reference

Europe PubMed Central

11 August 2017

Jake Lichterman

3

1 reference

Europe PubMed Central

11 August 2017

Yi-Tsung Lu

4

1 reference

Europe PubMed Central

11 August 2017

Yang Zhang

5

1 reference

Europe PubMed Central

11 August 2017

Mitch A Garcia

6

1 reference

Europe PubMed Central

11 August 2017

An-Jou Liang

8

1 reference

Europe PubMed Central

11 August 2017

Elisabeth Hodara

9

1 reference

Europe PubMed Central

11 August 2017

Haiyen E Zhau

10

1 reference

Europe PubMed Central

11 August 2017

Rafi S Ahmed

12

1 reference

Europe PubMed Central

11 August 2017

Daniel J Luthringer

13

1 reference

Europe PubMed Central

11 August 2017

Ker-Chau Li

15

1 reference

Europe PubMed Central

11 August 2017

Leland W K Chung

16

1 reference

Europe PubMed Central

11 August 2017

Zunfu Ke

17

1 reference

Europe PubMed Central

11 August 2017

Hsian-Rong Tseng

18

1 reference

Europe PubMed Central

11 August 2017

Edwin M Posadas

19

1 reference

Europe PubMed Central

11 August 2017

language of work or name

0 references

publication date

14 May 2015

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

121

1 reference

Europe PubMed Central

11 August 2017

18

1 reference

Europe PubMed Central

11 August 2017

3240-3251

1 reference

Europe PubMed Central

11 August 2017

Methods of integrating data to uncover genotype-phenotype interactions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Aggressive variants of castration-resistant prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Molecular analysis of circulating tumour cells-biology and biomarkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Cancer statistics, 2014

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Advanced technologies for studying circulating tumor cells at the protein level.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

NanoVelcro Chip for CTC enumeration in prostate cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

High-purity prostate circulating tumor cell isolation by a polymer nanofiber-embedded microchip for whole exome sequencing.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Polymer nanofiber-embedded microchips for detection, isolation, and molecular analysis of single circulating melanoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Tumour cell survival mechanisms in lethal metastatic prostate cancer differ between bone and soft tissue metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Circulating tumour cells and cancer stem cells: a role for proteomics in defining the interrelationships between function, phenotype and differentiation with potential clinical applications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Atypical metastases from prostate cancer: 10-year experience at a single institution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Site-specific cytomorphology of disseminated PC-3 prostate cancer cells visualized in vivo with fluorescent proteins.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Circulating tumor cells as biomarkers in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Highly efficient capture of circulating tumor cells by using nanostructured silicon substrates with integrated chaotic micromixers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Enhancement of U4/U6 small nuclear ribonucleoprotein particle association in Cajal bodies predicted by mathematical modeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Nuclear structure in cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Nuclear shape analysis for the assessment of local invasion and metastases in clinically localized prostate carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

2 October 2017

Visceral disease in castration-resistant prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

11 July 2018

Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

11 July 2018

Challenges in circulating tumour cell research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

23 September 2018

Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

23 September 2018

The prognostic importance of metastatic site in men with metastatic castration-resistant prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

23 September 2018

Detection of circulating tumor cells in different stages of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

23 September 2018

Case study of the morphologic variation of circulating tumor cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560974

23 September 2018

A new look at the statistical model identification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29455

21 January 2018

Estimating the Dimension of a Model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29455

21 January 2018

Challenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29455

21 January 2018

Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29455

21 January 2018

Prognostic significance of circulating tumor cell count in patients with metastatic hormone-sensitive prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29455

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating tumor cells predict survival in patients with metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29455

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating tumor cells: not all detected cells are bad and not all bad cells are detected

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29455

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29455

7 January 2021

based on heuristic

inferred from DOI database lookup

Nuclear morphometry is of independent prognostic value only in T1 prostatic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29455

7 January 2021

based on heuristic

inferred from DOI database lookup

A higher number of circulating tumor cells (CTC) in peripheral blood indicates poor prognosis in prostate cancer patients--a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25975562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The significance of hematogenous tumor cell clumps in the metastatic process

1 reference

https://pubmed.ncbi.nlm.nih.gov/25975562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CNCR.29455

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36030759&oldid=1612859436"